Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 251921 - 251940 out of 498644 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L04AC05) ustekinumab (adm: P) | STELARA IN.SO.PF.P 45MG/0,5ML (90MG/ML) BTx1PF.PEN x0,5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L04AC05) ustekinumab (adm: P) | STELARA INJ.SO.PFS 45MG/(90mg/ml) 0.5ML PF.SYR. BTx1PF SYRx0,5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L04AC05) ustekinumab (adm: P) | UZPRUVO INJ.SO.PFS 45MG/0,5ML (90MG/ML) BT X 1 P.F.SYR X 0.5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L04AC05) ustekinumab (adm: P) | PYZCHIVA INJ.SO.PFS 90MG/ML BT X 1 PF.SYR X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | SAMSUNGBIOEPISNLB.V.,THENETHERLANDS |
| Greece | (L04AC05) ustekinumab (adm: P) | STELARA IN.SO.PF.P 90MG/1ML BTx1PF.PEN x1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L04AC05) ustekinumab (adm: P) | STELARA INJ.SO.PFS 90MG/1ML BTx1PF SYRx1,0ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L04AC05) ustekinumab (adm: P) | UZPRUVO INJ.SO.PFS 90MG/ML BT X 1 P.F.SYR X 1ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | STADAARZNEIMITTELAG,GERMANY |
| Greece | (L04AC07) tocilizumab (adm: P) | ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x10ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AC07) tocilizumab (adm: P) | ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x20ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AC07) tocilizumab (adm: P) | ROACTEMRA C/S.SOL.IN 20MG/ML BTx1 VIAL x4ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AC07) tocilizumab (adm: P) | ROACTEMRA INJ.SO.PFS 162mg/PF.SYR BTx4 PF.SYR | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AC08) canakinumab (adm: P) | ILARIS INJ.SOL 150MG/ML BTx1VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L04AC10) secukinumab (adm: P) | COSENTYX IN.SO.PF.P 150MG/ML BTx1 Προγεμισμένη συσκευή τύπου πένας x 150mg/ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L04AC10) secukinumab (adm: P) | COSENTYX INJ.SOL 300MG/2ML (150MG/ML) 1 PF.PENx2 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NOVARTISEUROPHARMLIMITED,IRELAND |
| Greece | (L04AC12) brodalumab (adm: P) | KYNTHEUM INJ.SOL 210MG/1,5 ML (140 MG/ML) BTx2 PF.SYR x 1,5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | LEOPHARMAA/S,DENMARK |
| Greece | (L04AC16) guselkumab (adm: P) | TREMFYA INJ.SOL 100MG/1ML 1 PF.PEN x1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L04AC18) risankizumab (adm: P) | SKYRIZI INJ.SOL 150MG/ML BT X 1 PF.PEN | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
| Greece | (L04AC18) risankizumab (adm: P) | SKYRIZI INJ.SOL 150MG/ML BT X 1 PF.SYRS | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | ABBVIEDEUTSCHLANDGMBH&COKG,LUDWIGSHAFEN,GERMANY |
| Greece | (L04AC19) satralizumab (adm: P) | ENSPRYNG INJ.SOL 120MG/ML 1 PF.SYR. X 1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Neuromyelitis Optica | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L04AC21) bimekizumab (adm: P) | BIMZELX INJ.SOL 160MG/ML 2 PF.PENS X 1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | UCBPHARMAS.A.,BELGIUM |
Pages
